RTOG's History



RTOG Foundation, Inc. (RTOG)

The RTOG Foundation had its origins in 1997 when the RTOG Fund under the auspicious of the American College of Radiology, the grant holder for the Group, was created for the purpose of receiving and allocating corporate and private donations to allow the Group to sustain and expand important activities critical to its research mission. In August 2013 the RTOG Foundation incorporated as a non-profit foundation in the Commonwealth of Pennsylvania and in July 2014 RTOG Foundation, Inc. received its 501(c)3 non-profit status from the Internal Revenue Service

The RTOG Foundation continues the NCI-funded research of the Radiation Therapy Oncology Group through its membership in NRG Oncology.  In addition it has developed a portfolio of industry-funded research partnerships that see to further our understanding of effective therapies to improve the survival and quality of life of patients with cancer.

RTOG Foundation has maintained its relationships with the core members from the legacy Radiation Therapy Oncology Group and is able to access new members through its membership in NRG Oncology.  Today RTOG is a dynamic multidisciplinary research group with vigorous participation by physicians and other investigators at many of NCI’s designated cancer centers, major community centers, and many of the major academic and regional centers of Canada.  RTOG also has a strong international presence with access to sites on four continents.  This participation includes leadership from medical oncologists, surgical oncologists, pathologists, and laboratory scientists as well radiation oncologists. 

The RTOG Foundation Operations and Statistics & Data Management Center continue to be located at the offices of the American College of Radiology in Philadelphia, PA.

NRG Oncology (NRG)

In 2012 NCI announced plans to form a new consolidated and integrated NCI National Clinical Trials Network (NCTN) Program. As part of the restructuring required to create the NCTN, NCI reduced the number of NCI-supported adult clinical trial groups, now called lead protocol organizations (LPOs) and announced a new funding mechanism to support accrual from high accruing lead academic performing sites (LAPs). 

NRG became the successor LPO for RTOG's NCI-funded treatment protocols as of March 2014. NRG is a joint venture of the RTOG, the Gynecologic Oncology Group (GOG), and the National Surgical Breast and Bowel Project (NSABP).